Correlation Between Madrigal Pharmaceuticals and Humacyte
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Humacyte, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Humacyte.
Diversification Opportunities for Madrigal Pharmaceuticals and Humacyte
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Madrigal and Humacyte is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Humacyte go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Humacyte
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.63 times more return on investment than Humacyte. However, Madrigal Pharmaceuticals is 1.59 times less risky than Humacyte. It trades about 0.11 of its potential returns per unit of risk. Humacyte is currently generating about -0.03 per unit of risk. If you would invest 22,329 in Madrigal Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 12,416 from holding Madrigal Pharmaceuticals or generate 55.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Humacyte
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Humacyte |
Madrigal Pharmaceuticals and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Humacyte
The main advantage of trading using opposite Madrigal Pharmaceuticals and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. RenovoRx | Madrigal Pharmaceuticals vs. Scpharmaceuticals |
| Humacyte vs. Crinetics Pharmaceuticals | Humacyte vs. Viridian Therapeutics | Humacyte vs. Cytokinetics | Humacyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |